Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease

Withdrawn before enrolling · Not applicable

Conditions studied: Anemia

In brief

Anemia is a common disorder in infants with one working chamber of the heart that pumps blood. Anemia is when the level of healthy blood cells becomes too low. This may cause other health problems because red blood cells contain hemoglobin, which carries oxygen (needed for survival) to different parts of the body. This study will look at the role of iron in preventing anemia in infants with one pumping chamber. The importance of iron therapy will be examined. Hypothesis: Prophylactic use of iron in infants with single ventricle is effective in preventing anemia.

Key facts

Study ID

NCT00459225

Run by

Emory University

People needed

0

Starts

2007-04-01

Expected to finish

2013-06-01

Last updated by the study team

2014-12-09

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Single ventricle physiology (hypoplastic left heart syndrome [HLHS], tricuspid atresia, double inlet left ventricle [DILV], some double outlet right ventricle [DORV], heterotaxy, etc.)
• Age less than or equal to 2 months
• Saturations less than or equal to 90%
• Tolerating enteral feeds
• Informed consent being obtained

You may not qualify if…

• Age > 2 months
• Saturations > 90%
• Total parenteral nutrition
• Chronic kidney disease
• Prior iron therapy
• Hemolytic anemia

Where it is running

• Children's Healthcare of Atlanta — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.